Literature DB >> 6749355

Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial.

A J Ammann, R F Ashman, R H Buckley, W R Hardie, H J Krantmann, J Nelson, H Ochs, E R Stiehm, T Tiller, D W Wara, R Wedgwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6749355     DOI： 10.1016/0090-1229(82)90022-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  33 in total

1.  A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies.

Authors:  Melvin Berger
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.806

Review 2.  Clinical uses of intravenous immunoglobulin.

Authors:  S Jolles; W A C Sewell; S A Misbah
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

3.  Human intravenous immunoglobulin modulates monokine production in vitro.

Authors:  J P Andersson; U G Andersson
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

4.  Acquired immune dysfunction in homosexual men.

Authors:  A J Ammann
Journal:  West J Med       Date:  1982-11

5.  Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases.

Authors:  R I Schiff; L W Williams; R P Nelson; R H Buckley; W Burks; R A Good
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

6.  Alterations in the half-life and clearance of IgG during therapy with intravenous gamma-globulin in 16 patients with severe primary humoral immunodeficiency.

Authors:  R I Schiff; C Rudd
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

7.  The clinical use of intravenous immunoglobulin in pediatrics.

Authors:  V Wahn
Journal:  Indian J Pediatr       Date:  1987 Sep-Oct       Impact factor: 1.967

Review 8.  Intravenous immune globulin in primary immunodeficiency.

Authors:  M Haeney
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies.

Authors:  Mark R Stein; Robert P Nelson; Joseph A Church; Richard L Wasserman; Michael Borte; Christiane Vermylen; Johann Bichler
Journal:  J Clin Immunol       Date:  2008-09-24       Impact factor: 8.317

10.  Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies.

Authors:  C Cunningham-Rundles; Z Zhou; S Mankarious; S Courter
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.